Pay in 4 interest-free payments of $6.30 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
All products sold by Regentide are for laboratory and research use only
Obesity and adipose tissue research Type 2 diabetes and insulin resistance Knee osteoarthritis Obstructive sleep apnea Non-alcoholic steatohepatitis (NASH) Key Findings from the Literature 01Phase 2: 24.2% mean weight loss at 48 weeks at highest dose 02Phase 3 TRIUMPH-4: 28.7% mean weight loss at 68 weeks 03Highest weight loss efficacy of any obesity pharmacotherapy in clinical trials to date 04Glucagon receptor agonism adds hepatic lipolysis absent from GLP-1-only agents 1 Independent third-party lab reports for this peptide
Physicians and patients should remain vigilant for emerging or persistent issues as additional data arrives
Potent weight management: The multi-pathway action of retatrutide peptides has been shown to significantly enhance their ability to facilitate sustained and efficient weight loss
Many witnessed their blood sugar and heart rates improve as well
They are not for human consumption, medical use, veterinary use, therapeutic use, diagnostic use, or clinical application
